Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 1.1% – What’s Next?

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares were up 1.1% during mid-day trading on Friday . The stock traded as high as $10.40 and last traded at $9.78. Approximately 220,419 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 1,377,421 shares. The stock had previously closed at $9.67.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on shares of Tonix Pharmaceuticals in a research report on Monday, February 10th. They set a “sell” rating on the stock.

Tonix Pharmaceuticals Trading Up 0.8 %

The firm has a 50 day simple moving average of $28.22 and a 200 day simple moving average of $23.68. The company has a current ratio of 3.33, a quick ratio of 2.81 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $18.23 million, a PE ratio of 0.00 and a beta of 2.07.

Hedge Funds Weigh In On Tonix Pharmaceuticals

Several hedge funds and other institutional investors have recently bought and sold shares of TNXP. Geode Capital Management LLC grew its position in Tonix Pharmaceuticals by 1,600.1% in the 4th quarter. Geode Capital Management LLC now owns 1,971,894 shares of the company’s stock worth $650,000 after purchasing an additional 1,855,907 shares during the period. Jane Street Group LLC grew its position in shares of Tonix Pharmaceuticals by 5,932.3% during the 4th quarter. Jane Street Group LLC now owns 1,662,682 shares of the company’s stock valued at $548,000 after acquiring an additional 1,635,119 shares during the period. Point72 Asset Management L.P. bought a new stake in Tonix Pharmaceuticals during the fourth quarter valued at about $526,000. Northern Trust Corp bought a new stake in shares of Tonix Pharmaceuticals during the fourth quarter valued at approximately $162,000. Finally, PFG Investments LLC bought a new stake in Tonix Pharmaceuticals in the 4th quarter valued at $72,000. Institutional investors own 82.26% of the company’s stock.

About Tonix Pharmaceuticals

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults.